Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis

Acta Neuropathologica

Volumn 128, Issue 6, 2014, Pages 835-852

  Schubert, Manja ^a   Panja, Debabrata ^b   Haugen, Mette ^a   Bramham, Clive R ^b   Vedeler, Christian A ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Calbindin D28K; Calcium homeostasis; Onconeural Yo antibodies; Paraneoplastic cerebellar degeneration; Purkinje cell death; Purkinje cell specific protein 2

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; ANTIBODY; CALBINDIN 1; CALCIUM ION; CALPAIN; CALPAIN 1; CALPAIN 2; CASPASE 3; CEREBELLAR DEGENERATION RELATED PROTEIN 2 ANTIBODY; CEREBELLAR DEGENERATION RELATED PROTEIN 2 LIGAND ANTIBODY; PROTEIN KINASE C GAMMA; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; ANTIGEN CDR2L, HUMAN; AUTOANTIBODY; AUTOANTIGEN; CALCIUM; CALCIUM CHANNEL N TYPE; CALPAIN 2, RAT; CDR2 PROTEIN, HUMAN; NERVE PROTEIN; PCP-2 PROTEIN, RAT; PROTEIN KINASE C; VOLTAGE-DEPENDENT CALCIUM CHANNEL (P-Q TYPE);

ARTICLE; BLOOD BRAIN BARRIER; CALCIUM HOMEOSTASIS; CASE REPORT; CONTROLLED STUDY; FEMALE; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; NONHUMAN; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; RAT; WESTERN BLOTTING; AGED; ANIMAL; DRUG EFFECTS; HOMEOSTASIS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; RABBIT; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUE; VERY ELDERLY; WISTAR RAT;

AGED; AGED, 80 AND OVER; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CALBINDIN 1; CALCIUM; CALCIUM CHANNELS, N-TYPE; CALPAIN; FEMALE; HOMEOSTASIS; HUMANS; MAP KINASE SIGNALING SYSTEM; NERVE TISSUE PROTEINS; PARANEOPLASTIC CEREBELLAR DEGENERATION; PROTEIN KINASE C; PURKINJE CELLS; RABBITS; RATS, WISTAR; TISSUE CULTURE TECHNIQUES;

EID: 84922087339     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1351-6     Document Type: Article

References (75)

1. Airaksinen MS, Eilers J, Garaschuk O, Thoenen H, Konnerth A, Meyer M (1997) Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene. Proc Natl Acad Sci USA 94(4):1488–1493
2. Albert ML, Austin LM, Darnell RB (2000) Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol 47(1):9–17
3. Albert ML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, Darnell RB (1998) Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 4(11):1321–1324
4. Barski JJ, Hartmann J, Rose CR, Hoebeek F, Mörl K, Noll-Hussong M, De Zeeuw CI, Konnerth A, Meyer M (2003) Calbindin in cerebellar Purkinje cells is a critical determinant of the precision of motor coordination. J Neurosci 23(8):3469–3477
5. Baudry M, Chou MM, Bi X (2013) Targeting calpain in synaptic plasticity. Expert Opin Ther Targets 17(5):579–592
6. Berridge MJ (1998) Neuronal calcium signaling. Neuron 21(1):13–26
7. De Beukelaar JW, Sillevis Smitt PA (2006) Managing paraneoplastic neurological disorders. Oncologist 11(3):292–305
8. Bright R, Mochly-Rosen D (2005) The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke J Cereb Circ 36(12):2781–2790
9. Buki A, Farkas O, Doczi T, Povlishock JT (2003) Preinjury administration of the calpain inhibitor MDL-28170 attenuates traumatically induced axonal injury. J Neurotrauma 20(3):261–268
10. Carpenter EL, Vance BA, Klein RS, Voloschin A, Dalmau J, Vonderheide RH (2008) Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration. J Neuroimmunol 193(1–2):173–182
11. 28k are structurally and functionally important. Biochemistry (Mosc) 44(2):684–693
12. Cheung ECC, Slack RS (2004) Emerging role for ERK as a key regulator of neuronal apoptosis. Sci STKE Signal Transduct Knowl Environ 251:PE45
13. Cho S, Wood A, Bowlby MR (2007) Brain slices as models for neurodegenerative disease and screening platforms to identify novel therapeutics. Curr Neuropharmacol 5(1):19–33
14. Congdon EE, Gu J, Sait HBR, Sigurdsson EM (2013) Antibody uptake into neurons occurs primarily via clathrin-dependent Fc receptor endocytosis and is a prerequisite for acute tau protein clearance. J Biol Chem 288(49):35452–35465
15. Corradi JP, Yang C, Darnell JC, Dalmau J, Darnell RB (1997) A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues. J Neurosci 17(4):1406–1415
16. Crocker SJ, Smith PD, Jackson-Lewis V et al (2003) Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson’s disease. J Neurosci 23(10):4081–4091
17. Czogalla A, Sikorski AF (2005) Spectrin and calpain: a “target” and a “sniper” in the pathology of neuronal cells. Cell Mol Life Sci 62(17):1913–1924
18. Dahm L, Ott C, Steiner J et al (2014) Seroprevalence of autoantibodies against brain antigens in health and disease: brain-targeting autoantibodies. Ann Neurol 76(1):82–94
19. Derkach V (2011) Zooming in on AMPA receptor regulation by CaMKII. Nat Neurosci 14(6):674–675
20. Diamond B, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT (2009) Losing your nerves? Maybe it’s the antibodies. Nat Rev Immunol 9(6):449–456
21. Dupont J-L, Fourcaudot E, Beekenkamp H, Poulain B, Bossu J-L (2006) Synaptic organization of the mouse cerebellar cortex in organotypic slice cultures. Cerebellum Lond Engl 5(4):243–256
22. Eichler TW, Totland C, Haugen M, Qvale TH, Mazengia K, Storstein A, Haukanes BI, Vedeler CA (2013) CDR2L antibodies: a new player in paraneoplastic cerebellar degeneration. PLoS One 8(6):e66002
23. Endo S, Launey T (2003) ERKs regulate PKC-dependent synaptic depression and declustering of glutamate receptors in cerebellar Purkinje cells. Neuropharmacology 45(6):863–872
24. Fierro L, DiPolo R, Llano I (1998) Intracellular calcium clearance in Purkinje cell somata from rat cerebellar slices. J Physiol 510(Pt 2):499–512
25. Fujishima K, Horie R, Mochizuki A, Kengaku M (2012) Principles of branch dynamics governing shape characteristics of cerebellar Purkinje cell dendrites. Development 139(18):3442–3455
26. Gafni J, Ellerby LM (2002) Calpain activation in Huntington’s disease. J Neurosci 22(12):4842–4849
27. +-channel activators in Cacna1a(S218L) mutant mice. J Neurosci 32(44):15533–15546
28. Ghoumari AM, Dusart I, El-Etr M, Tronche F, Sotelo C, Schumacher M, Baulieu E-E (2003) Mifepristone (RU486) protects Purkinje cells from cell death in organotypic slice cultures of postnatal rat and mouse cerebellum. Proc Natl Acad Sci 100(13):7953–7958
29. Giorgi C, Agnoletto C, Baldini C et al (2010) Redox control of protein kinase C: cell- and disease-specific aspects. Antioxid Redox Signal 13(7):1051–1085
30. Greenlee JE (2006) Anti-Yo autoimmunity; dangerous for the brain but not the tumor? J Neurol Sci 250(1–2):1–2
31. Greenlee JE, Clawson SA, Hill KE, Wood BL, Tsunoda I, Carlson NG (2010) Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. J Neuropathol Exp Neurol 69(10):997–1007
32. 2+ signaling in Purkinje neurons. Cell Calcium 37(5):459–466
33. Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE (2009) Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J Neuroinflammation 6:31
34. Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609–642
35. Junttila MR, Li S-P, Westermarck J (2008) Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J Off Publ Fed Am Soc Exp Biol 22(4):954–965
36. Kawamura M, Nakajima W, Ishida A, Ohmura A, Miura S, Takada G (2005) Calpain inhibitor MDL 28170 protects hypoxic-ischemic brain injury in neonatal rats by inhibition of both apoptosis and necrosis. Brain Res 1037(1–2):59–69
37. Kim JH (2005) Overexpression of calbindin-D28K in hippocampal progenitor cells increases neuronal differentiation and neurite outgrowth. FASEB J. doi:10.1096/fj.05-4826fje
38. Kim BJ, Lee SY, Kim HW, Park E-J, Kim J, Kim SJ, So I, Jeon J-H (2009) Optimized immunohistochemical analysis of cerebellar purkinje cells using a specific biomarker, calbindin D28k. Korean J Physiol Pharmacol 13(5):373
39. 2+ channels in a dose-dependent manner. Brain Res Mol Brain Res 132(1):73–86
40. Kordasiewicz HB, Gomez CM (2007) Molecular pathogenesis of spinocerebellar ataxia type 6. Neurother J Am Soc Exp Neurother 4(2):285–294
41. Leist M, Nicotera P (1998) Calcium and neuronal death. Rev Physiol Biochem Pharmacol 132:79–125
42. Ling C, Verbny YI, Banks MI, Sandor M, Fabry Z (2008) In situ activation of antigen-specific CD8+ T cells in the presence of antigen in organotypic brain slices. J Immunol 180(12):8393–8399
43. Lonchamp E, Dupont J-L, Beekenkamp H, Poulain B, Bossu J-L (2006) The mouse cerebellar cortex in organotypic slice cultures: an in vitro model to analyze the consequences of mutations and pathologies on neuronal survival, development, and function. Crit Rev Neurobiol 18(1–2):179–186
44. Lossi L, Alasia S, Salio C, Merighi A (2009) Cell death and proliferation in acute slices and organotypic cultures of mammalian CNS. Prog Neurobiol 88(4):221–245
45. Metzger F, Kapfhammer JP (2000) Protein kinase C activity modulates dendritic differentiation of rat Purkinje cells in cerebellar slice cultures. Eur J Neurosci 12(6):1993–2005
46. Metzger F, Kapfhammer JP (2003) Protein kinase C: its role in activity-dependent Purkinje cell dendritic development and plasticity. Cerebellum Lond Engl 2(3):206–214
47. Nakamura K, Hirai H, Torashima T et al (2007) CD3 and immunoglobulin G Fc receptor regulate cerebellar functions. Mol Cell Biol 27(14):5128–5134
48. O’Donovan KJ, Diedler J, Couture GC, Fak JJ, Darnell RB (2010) The onconeural antigen cdr2 is a novel APC/C target that acts in mitosis to regulate c-myc target genes in mammalian tumor cells. PLoS One 5(4):e10045
49. Okano HJ, Park WY, Corradi JP, Darnell RB (1999) The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev 13(16):2087–2097
50. Peden AH, Ironside JW (2012) Molecular pathology in neurodegenerative diseases. Curr Drug Targets 13(12):1548–1559
51. Roberts WK, Darnell RB (2004) Neuroimmunology of the paraneoplastic neurological degenerations. Curr Opin Immunol 16(5):616–622
52. Rodriguez M, Truh LI, O’Neill BP, Lennon VA (1988) Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells. Neurology 38(9):1380–1386
53. Saito K, Elce JS, Hamos JE, Nixon RA (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90(7):2628–2632
54. Sakai K, Kitagawa Y, Saiki S, Saiki M, Hirose G (2004) Effect of a paraneoplastic cerebellar degeneration-associated neural protein on B-myb promoter activity. Neurobiol Dis 15(3):529–533
55. Sakai K, Shirakawa T, Li Y, Kitagawa Y, Hirose G (2002) Interaction of a paraneoplastic cerebellar degeneration-associated neuronal protein with the nuclear helix-loop-helix leucine zipper protein MRG X. Mol Cell Neurosci 19(4):477–484
56. Santomasso BD, Roberts WK, Thomas A, Williams T, Blachère NE, Dudley ME, Houghton AN, Posner JB, Darnell RB (2007) A T-cell receptor associated with naturally occurring human tumor immunity. Proc Natl Acad Sci USA 104(48):19073–19078
57. 2+ buffer proteins in excitable cells. Biochim Biophys Acta 1820(8):1294–1303
58. Seki T, Abe-Seki N, Kikawada T, Takahashi H, Yamamoto K, Adachi N, Tanaka S, Hide I, Saito N, Sakai N (2010) Effect of trehalose on the properties of mutant {gamma}PKC, which causes spinocerebellar ataxia type 14, in neuronal cell lines and cultured Purkinje cells. J Biol Chem 285(43):33252–33264
59. Stabach PR, Cianci CD, Glantz SB, Zhang Z, Morrow JS (1997) Site-directed mutagenesis of alpha II spectrin at codon 1175 modulates its mu-calpain susceptibility. Biochemistry (Mosc) 36(1):57–65
60. Steinberg SF (2008) Structural basis of protein kinase C isoform function. Physiol Rev 88(4):1341–1378
61. Storstein A, Krossnes BK, Vedeler CA (2009) Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies. Acta Neurol Scand 120(1):64–67
62. Storstein A, Monstad SE, Honnorat J, Vedeler CA (2004) Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum. J Neuroimmunol 155(1–2):150–154
63. Storstein A, Vedeler CA (2007) Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects. Adv Clin Chem 44:143–185
64. Sulaiman P, Fina M, Feddersen R, Vardi N (2010) Ret-PCP2 colocalizes with protein kinase C in a subset of primate ON cone bipolar cells. J Comp Neurol 518(7):1098–1112
65. Sutton IJ, Steele J, Savage CO, Winer JB, Young LS (2004) An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies. J Neuroimmunol 150(1–2):98–106
66. Takanaga H, Mukai H, Shibata H, Toshimori M, Ono Y (1998) PKN interacts with a paraneoplastic cerebellar degeneration-associated antigen, which is a potential transcription factor. Exp Cell Res 241(2):363–372
67. Tanaka M (2009) Dendrite formation of cerebellar Purkinje cells. Neurochem Res 34(12):2078–2088
68. Tanaka K, Augustine GJ (2008) A positive feedback signal transduction loop determines timing of cerebellar long-term depression. Neuron 59(4):608–620
69. Todorov B, Kros L, Shyti R et al (2012) Purkinje cell-specific ablation of Cav2.1 channels is sufficient to cause cerebellar ataxia in mice. Cerebellum Lond Engl 11(1):246–258
70. Totland C, Aarskog NK, Eichler TW, Haugen M, Nøstbakken JK, Monstad SE, Salvesen HB, Mørk S, Haukanes BI, Vedeler CA (2011) CDR2 antigen and Yo antibodies. Cancer Immunol Immunother CII 60(2):283–289
71. Totland C, Ying M, Haugen M, Mazengia K, Storstein A, Aarseth J, Martinez A, Vedeler C (2013) Avidity of onconeural antibodies is of clinical relevance. Cancer Immunol Immunother CII 62(8):1393–1396
72. Vernino S (2012) Paraneoplastic cerebellar degeneration. Handb Clin Neurol 103:215–223
73. Wang JQ, Arora A, Yang L, Parelkar NK, Zhang G, Liu X, Choe ES, Mao L (2005) Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity. Mol Neurobiol 32(3):237–249
74. Wernyj RP, Mattson MP, Christakos S (1999) Expression of calbindin-D28k in C6 glial cells stabilizes intracellular calcium levels and protects against apoptosis induced by calcium ionophore and amyloid beta-peptide. Brain Res Mol Brain Res 64(1):69–79
75. Zadran S, Bi X, Baudry M (2010) Regulation of calpain-2 in neurons: implications for synaptic plasticity. Mol Neurobiol 42(2):143–150